Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10 - PubMed (original) (raw)
Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10
M Connors et al. J Virol. 1994 Aug.
Abstract
In previous studies, children immunized with a formalin-inactivated respiratory syncytial virus vaccine (FI-RSV) developed severe pulmonary disease with greater frequency than did controls during subsequent natural RSV infection. In earlier efforts to develop an animal model for this phenomenon, extensive pulmonary histopathology developed in FI-RSV-immunized cotton rats and mice subsequently challenged with RSV. In mice, depletion of CD4+ T cells at the time of RSV challenge completely abrogated this histopathology. Furthermore, the predominant cytokine mRNA present in lungs of FI-RSV-immunized mice during subsequent infection with RSV was that characteristically secreted by Th2 T cells, namely interleukin-4 (IL-4). In the present studies, we sought to determine the relative contributions of gamma interferon (IFN-gamma), IL-2, IL-4, and IL-10 to the lymphocytic infiltration into the lungs observed following RSV challenge of mice previously immunized with FI-RSV. Mice previously immunized with FI-RSV or infected with RSV were depleted of IFN-gamma, IL-2, IL-4, or IL-10 immediately before RSV challenge, and the magnitude of inflammatory cell infiltration around bronchioles and pulmonary blood vessels was quantified. The phenomenon of pulmonary-histopathology potentiation by FI-RSV was reproduced in the present study, thereby allowing us to investigate the effect of cytokine depletion on the process. Simultaneous depletion of both IL-4 and IL-10 completely abrogated pulmonary histopathology in FI-RSV-immunized mice. Depletion of IL-4 alone significantly reduced bronchiolar, though not perivascular, histopathology. Depletion of IL-10 alone had no effect. Depletion of IFN-gamma, IL-2, or both together had no effect on the observed histopathology. These data indicate that FI-RSV immunization primes for a Th2-, IL-4-, and IL-10-dependent inflammatory response to subsequent RSV infection. It is possible that this process played a role in enhanced disease observed in infants and children immunized with FI-RSV.
Similar articles
- Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.
Connors M, Kulkarni AB, Firestone CY, Holmes KL, Morse HC 3rd, Sotnikov AV, Murphy BR. Connors M, et al. J Virol. 1992 Dec;66(12):7444-51. doi: 10.1128/JVI.66.12.7444-7451.1992. J Virol. 1992. PMID: 1433525 Free PMC article. - Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Boelen A, Andeweg A, Kwakkel J, Lokhorst W, Bestebroer T, Dormans J, Kimman T. Boelen A, et al. Vaccine. 2000 Nov 22;19(7-8):982-91. doi: 10.1016/s0264-410x(00)00213-9. Vaccine. 2000. PMID: 11115725 - Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR, Graham BS. Johnson TR, et al. Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.
Cited by
- Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract.
Walpita P, Johns LM, Tandon R, Moore ML. Walpita P, et al. PLoS One. 2015 Jul 14;10(7):e0130755. doi: 10.1371/journal.pone.0130755. eCollection 2015. PLoS One. 2015. PMID: 26172453 Free PMC article. - Need for a safe vaccine against respiratory syncytial virus infection.
Kim JY, Chang J. Kim JY, et al. Korean J Pediatr. 2012 Sep;55(9):309-15. doi: 10.3345/kjp.2012.55.9.309. Epub 2012 Sep 14. Korean J Pediatr. 2012. PMID: 23049587 Free PMC article. - Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.
Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G, Rabatic S. Bendelja K, et al. Clin Exp Immunol. 2000 Aug;121(2):332-8. doi: 10.1046/j.1365-2249.2000.01297.x. Clin Exp Immunol. 2000. PMID: 10931150 Free PMC article. - C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression.
Melendi GA, Hoffman SJ, Karron RA, Irusta PM, Laham FR, Humbles A, Schofield B, Pan CH, Rabold R, Thumar B, Thumar A, Gerard NP, Mitzner W, Barnum SR, Gerard C, Kleeberger SR, Polack FP. Melendi GA, et al. J Virol. 2007 Jan;81(2):991-9. doi: 10.1128/JVI.01783-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079327 Free PMC article. - Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus.
Chen J, Tan S, Avadhanula V, Moise L, Piedra PA, De Groot AS, Bahl J. Chen J, et al. PLoS Comput Biol. 2023 Jan 10;19(1):e1010360. doi: 10.1371/journal.pcbi.1010360. eCollection 2023 Jan. PLoS Comput Biol. 2023. PMID: 36626370 Free PMC article.
References
- Pediatrics. 1992 Jul;90(1 Pt 2):137-43 - PubMed
- Eur J Immunol. 1993 Nov;23(11):3043-9 - PubMed
- Infect Immun. 1992 Sep;60(9):3725-30 - PubMed
- J Exp Med. 1991 Jan 1;173(1):159-66 - PubMed
- J Exp Med. 1991 Mar 1;173(3):775-8 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials